Shield Therapeutics shares pressured by legal worries

By
0 mins. to read
Shield Therapeutics shares pressured by legal worries
Master Investor Magazine

Never miss an issue of Master Investor Magazine – sign-up now for free!

Read the latest Master Investor Magazine

AIM-listed pharmaceutical firm Shield Therapeutics (LON:STX) has seen its share price drop by 3.55% to 109.55p (as of 13:05 BST) after legal proceedings were lodged against it. Teva Pharmaceuticals has filed an appeal to the Opposition Division of the European Patent Office regarding the decision on a patent held by Shield.

Management said that the company will defend its intellectual property and believe that the board of appeal should uphold the original decision.

Take part in our poll

Which investment platforms do you use?

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

YOUR FREE INVESTMENT MAG

Get real investment insights from some of the best minds in the business - with our free Master Investor Magazine.